Holen Sie sich die Stockscreener-App
26.87
0.07%
0.02
Handel nachbörslich:
26.87
Schlusskurs vom Vortag:
$26.85
Offen:
$26.91
24-Stunden-Volumen:
592.89K
Relative Volume:
0.39
Marktkapitalisierung:
$1.33B
Einnahmen:
$224.45M
Nettoeinkommen (Verlust:
$-95.27M
KGV:
-13.92
EPS:
-1.93
Netto-Cashflow:
$-43.74M
1W Leistung:
+1.21%
1M Leistung:
-1.79%
6M Leistung:
+52.41%
1J Leistung:
-27.67%
1-Tages-Spanne:
$26.85
$27.22
1-Wochen-Bereich:
$26.55
$27.22
52-Wochen-Spanne:
$13.50
$36.88
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Vergleichen Sie STAA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.87 | 1.33B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
Alcon, STAAR Surgical see US antitrust waiting period expire - MLex
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR - MarketScreener
$1.5B Eye Care Merger Progresses: Alcon's Premium Buyout of STAAR Surgical Clears Key Regulatory Hurdle - Stock Titan
Broadwood files definitive proxy, STAAR reaffirms Alcon merger - Investing.com
Broadwood files definitive proxy, STAAR reaffirms Alcon merger By Investing.com - Investing.com UK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders - Benzinga
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC) - Seeking Alpha
Yunqi Capital Ltd Increases Stake in Staar Surgical Co - GuruFocus
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more (PFE:NYSE) - Seeking Alpha
Gwangju Shinsegae Eye Clinic Selected as Best ICL Center for 2 Consecutive Years - 아시아경제
Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors - MSN
STAAR Surgical (STAA) Proposes $28 All-Cash Merger with Alcon - GuruFocus
59% Premium at $28 Per Share: STAAR Surgical Board Champions Alcon Merger as China Sales Decline Continues - Stock Titan
Assenagon Asset Management S.A. Acquires 111,686 Shares of STAAR Surgical Company $STAA - MarketBeat
Alcon’s Deal For STAAR Surgical Faces Pushback From Major Shareholder - Finimize
Intraocular Lens Market Size, Share, Growth, & Demand | Industry Report 2033 - Straits Research
STAAR Surgical (NASDAQ:STAA) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Alcon AG stock hits 52-week low at $74.83 By Investing.com - Investing.com South Africa
Broadwood opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com South Africa
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates - GlobeNewswire
Broadwood opposes Alcon’s acquisition of STAAR Surgical - Investing.com
Broadwood Partners (27.5% Owner) Opposes STAAR's $28/Share Alcon Deal | STAA Stock News - Stock Titan
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why - Stocktwits
Shareholder Rebellion Intensifies as Staar Surgical Acquisition Reaches Critical Juncture - AD HOC NEWS
STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal - Investing.com Nigeria
STAAR confirms no competing bids emerged during Alcon merger window By Investing.com - Investing.com Australia
Yunqi Capital opposes STAAR Surgical’s merger with Alcon By Investing.com - Investing.com South Africa
Staar has no competing bids, another shareholder rejects Alcon buy - BioWorld MedTech
STAAR confirms no competing bids emerged during Alcon merger window - Investing.com
Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - MSN
Alcon’s Staar Surgical acquisition clears hurdle as ‘window shop’ period closes - MassDevice
51% Premium Deal Stands: STAAR's $28/Share Alcon Merger Remains Unchallenged After 45-Day Shop Period - Stock Titan
Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
Yunqi Capital opposes STAAR Surgical’s merger with Alcon - Investing.com
Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ) - Seeking Alpha
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Bluefield Daily Telegraph
$28 vs Previous $55 Offer: Major STAAR Surgical Investor Yunqi Capital Fights Against 'Undervalued' Alcon Deal - Stock Titan
STAAR SURGICAL CO. STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of STAAR Surgical Company (NASDAQ: STAA) Proposed Stockholder Buyout and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
STAAR Surgical Company (NASDAQ:STAA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Daily Brief Australia: Alcidion, D3 Energy, Percheron Therapeutics and more - Smartkarma
European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9) - Ophthalmology Times Europe
Is STAAR Surgical Poised for a Turnaround After Mixed Earnings in 2025? - Yahoo Finance
Pinnacle Investment Management Ltd Invests $1.16 Million in STAAR Surgical Company $STAA - MarketBeat
Staar Surgical’s board urges stockholders to approve Alcon acquisition in face of scrutiny - MassDevice
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Cataract Devices Market Estimated at USD 14.68 Billion in 2025 | - openPR.com
Dr. Jason Brinton Selected as Principal Investigator for Landmark FDA Study Demonstrating Superior Safety and Efficacy of EVO ICL Technology - columbiadailyherald.com
Jones Financial Companies Lllp Increases Stock Holdings in STAAR Surgical Company $STAA - MarketBeat
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
1.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):